COEP logo

Coeptis Therapeutics (COEP) Company Overview

Profile

Full Name:

Coeptis Therapeutics Holdings, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

December 17, 2020

Indexes:

Not included

Description:

Coeptis Therapeutics (COEP) is a biotechnology company focused on developing innovative cell therapies for cancer treatment. They aim to improve patient outcomes by harnessing the power of the immune system to target and destroy cancer cells more effectively.

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

Nov 9, 2023

Recent annual earnings:

N/A
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Dec 31, 2024

Analyst ratings

Recent major analysts updates

Sep 22, 23 Ladenburg Thalmann
Buy
May 18, 23 EF Hutton
Buy
May 10, 23 EF Hutton
Buy
Apr 19, 23 JonesTrading
Buy
Apr 5, 23 EF Hutton
Buy
Mar 29, 23 EF Hutton
Buy
Dec 13, 22 EF Hutton
Buy
Dec 12, 22 EF Hutton
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Coeptis Therapeutics?
  • Does Coeptis Therapeutics pay dividends?
  • What sector is Coeptis Therapeutics in?
  • What industry is Coeptis Therapeutics in?
  • What country is Coeptis Therapeutics based in?
  • When did Coeptis Therapeutics go public?
  • Is Coeptis Therapeutics in the S&P 500?
  • Is Coeptis Therapeutics in the NASDAQ 100?
  • Is Coeptis Therapeutics in the Dow Jones?
  • When was Coeptis Therapeutics's last earnings report?
  • When does Coeptis Therapeutics report earnings?
  • Should I buy Coeptis Therapeutics stock now?

What is the ticker symbol for Coeptis Therapeutics?

The ticker symbol for Coeptis Therapeutics is NASDAQ:COEP

Does Coeptis Therapeutics pay dividends?

No, Coeptis Therapeutics does not pay dividends

What sector is Coeptis Therapeutics in?

Coeptis Therapeutics is in the Healthcare sector

What industry is Coeptis Therapeutics in?

Coeptis Therapeutics is in the Biotechnology industry

What country is Coeptis Therapeutics based in?

Coeptis Therapeutics is headquartered in United States

When did Coeptis Therapeutics go public?

Coeptis Therapeutics's initial public offering (IPO) was on December 17, 2020

Is Coeptis Therapeutics in the S&P 500?

No, Coeptis Therapeutics is not included in the S&P 500 index

Is Coeptis Therapeutics in the NASDAQ 100?

No, Coeptis Therapeutics is not included in the NASDAQ 100 index

Is Coeptis Therapeutics in the Dow Jones?

No, Coeptis Therapeutics is not included in the Dow Jones index

When was Coeptis Therapeutics's last earnings report?

Coeptis Therapeutics's most recent earnings report was on Nov 9, 2023

When does Coeptis Therapeutics report earnings?

The date for Coeptis Therapeutics's next earnings report has not been announced yet

Should I buy Coeptis Therapeutics stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions